Anand Kiran Parikh

Director, Chief Operating Officer; Director, President and CEO · 5 filings · Latest: Jul 21, 2026

Faeth Therapeutics, Inc.

Sensei Biotherapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
FTH	Anand Kiran Parikh	Director, President and CEO	Jun 22, 2026	Option Exercise	$1.16	53,465	$62.0K	817,699	Jun 24 10:55 PM
FTH	Anand Kiran Parikh	Director, President and CEO	Jun 22, 2026	Purchase	$19.76	2,806	$55.4K	764,234	Jun 24 10:55 PM